Fidia S.p.A. (BIT:FDA) signed a binding agreement to acquire Integrated portfolio of anti-inflammatory drugs of Sanofi on March 23, 2021. The transaction is subject to Antitrust and government authorities for FDI purposes. Luca Liistro of Chiomenti Studio Legal acted as a legal advisor to Fidia S.p.A. Gael Saint Olive of Jones Day acted as legal advisor to Sanofi.

Fidia S.p.A. (BIT:FDA) completed the acquisition of Integrated portfolio of anti-inflammatory drugs of Sanofi on June 30, 2021.